Sign Up to like & get
recommendations!
1
Published in 2020 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-020-05381-5
Abstract: We present the first detailed report of acneiform eruptions in patients on CTLA-4 inhibitor therapy. Acneiform eruptions commonly occur (up to 75–100%) as a cutaneous adverse event associated with EGFR inhibition; however, acneiform eruptions have…
read more here.
Keywords:
ctla inhibitor;
inhibitor therapy;
acneiform eruptions;
cutaneous adverse ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Dermatologic therapy"
DOI: 10.1111/dth.15412
Abstract: Epidermal growth factor receptor inhibitors (EGFRi) are now standard of care in patients with EGFR mutations in non-small cell lung cancer (NSCLC) and are increasingly being used in other EGFR mutated cancers, including gastrointestinal, and…
read more here.
Keywords:
acneiform;
review;
epidermal growth;
acneiform eruptions ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Cosmetic Dermatology"
DOI: 10.1111/jocd.12360
Abstract: We describe five cases of acneiform eruption caused by vitamin B12 in five females aged 37, 32, 62, 29, and 21 years, respectively. The eruption appeared from 1 week to 5 months after the beginning…
read more here.
Keywords:
eruptions caused;
acneiform eruptions;
five cases;
vitamin b12 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Postgraduate Medical Journal"
DOI: 10.1136/postgradmedj-2020-137756
Abstract: Propranolol is a frequently prescribed non-selective beta-blocker for the management of hypertension, cardiac arrhythmias, post myocardial infarction, thyrotoxicosis, tremors and migraine prophylaxis.1 Although rare, it may produce dermatological side effects like exacerbation of psoriasis, atopic…
read more here.
Keywords:
eruptions revisiting;
acneiform eruptions;
induced acneiform;
propranolol ... See more keywords